×

News & Events

FDA’s New MQSA rules go into effect September 10th, 2024: Are you ready? OmniCare is!

FDA’s New MQSA rules go into effect September 10th, 2024: Are you ready? OmniCare is!

Are you ready for these final rules?   They mandate quite a few changes, including how a patient’s breast density is reported through the “lay” letter, timing of certain results to the patients and more.

If you are an OmniCare customer, be rest assured that all current versions of OmniCare comply with MQSA.  Contact us if you would like to review the Final MQSA Rules with us.  If you are a healthcare facility doing mammography, we can help. Please reach out to your Insight Support representative at 1-800-643-0123 and choose option 2, or click here for more info.

Read More

MARCH 2023: OmniCare version 8 already compliant with MQSA Final Rule

MammographyMQSA

“On March 10, 2023, the FDA issued the Final Rule to Amend the MQSA Regulations. These updated requirements are to be implemented within 18 months after publication in the Federal Register. As noted in the final rule, the FDA concluded that 18 months was a practical timeframe for facilities to implement these requirements without undue hardship. Facilities are not precluded from including the required breast density notification prior to 18 months; however, facilities subject to MQSA must comply with all the requirements, including the breast density notification, no later than September 10, 2024.”

—FDA’s MQSA webpage

As a result of Insight’s forward-thinking and proactive development team’s efforts, OmniCare version 8 already contains all the necessary changes to fully comply with these final MQSA rules, including the updated density language required to be delivered in patient result letters.

OmniCare is a widely used for Breast Centers, Lung Cancer Screening, Incidental Imaging Findings, Patient Navigation, Pap Smears and more.  For more information go to: www.insightmed.com, or call 800-643-0123.

Read More

OCTOBER 2022: OmniCare assists practices with Interoperability connectivity regional Health Information Exchanges

Using Insight’s OmniCare HL7 export capablities, The Women’s Imaging Center in Colorado has made it easier for physicians to access their patients’ critical information by sending their radiology reports to CORHIO, Colorado’s Health Information Exchange, which is part of the Contexture network.

This is just one of many technologies available on the OmniCare platform to assist in data interoperability and simplifying workflows, joining OmniCare’s paperless workflow and results automation.

Read More

JUNE 2022: OMNICARE GOES LIVE FOR PAP SMEARS, HPV TESTING AND CERVICAL CANCER SCREENING

The OmniCare Disease Management Platform has successfully launched a Cervical Cancer Patient Management System.  Now lab results can be integrated into OmniCare which then provides all the tracking, follow up, outcomes and reporting that is the trademark of the Omnicare Platform.

Initially OmniCare for Cervical Cancer is live in 2 health systems:  The first is The Westchester Medical Group: which has locations throughout NY and also uses OmniCare for it’s Breast and Lung Programs.  The second is The Midwest Health Center, of Norfolk, NE, a long time Insight Client of 17 years.

In August 2018, updated screening guidelines were released by the United States Preventive Services Task Force (USPSTF), which calls for cancer screenings

More than 13,000 women in the United States will be diagnosed with cervical cancer each year, and more than 4,000 of women will die. Cervical cancer is the fourth most common type of cancer for women worldwide, but because it develops over time, it is also one of the most preventable types of cancer.

OmniCare is a widely used for Breast Centers, Lung Cancer Screening, Incidental Imaging Findings, Patient Navigation, Pap Smears and more.  For more information go to: www.insightmed.com, or call 800-643-0123.

Read More

May 2022: OmniCare v8 introduces Portal Integration for your Patient and Physician Communications

Encino, CA

Insight announces that it has launched Patient Portal Integration with its OmniCare Version 8, Disease Management Platforms.   Patient and Physician result and follow up letters can now be uploaded to your Patient Portal along with options of email and texting.   This integration works with systems such as Athena, Epic, Cerner and other third party platforms. 

In addition, our advanced communications module can send clinical notes and documentation made in OmnICare’s patient dashboards and navigation systems to your EHR and Patient Chart.  Future upgrades to this integration will include patient input of risk history factors to help determine a patient’s cancer risk assessment.

OmniCare is a widely used for Breast Centers, Lung Cancer Screening, Incidental Imaging Findings, Patient Navigation, Pap Smears and more.  For more information go to: www.insightmed.com, or call 800-643-0123.

September Update:

Portal Integration with Athena goes live at 2 health systems:  Elevate Women’s Health and Imaging Centers, with locations throughout the Denver Area, and Westchester Medical Group, with locations throughout the Greater NYC area.

Read More

April 2022: ACR announces new version 1.6 of the Lung Cancer Screening Registry (LCSR)

Encino, CA

Lung cancer kills more people each year than breast, colorectal and prostate cancer combined. Annual lung cancer screening with low-dose computed tomography (LDCT)  in high-risk patients significantly reduces lung cancer deaths.[1],[2] 

Yet, less than 15% of Americans who met previous criteria are tested.[3],[4]  The American Cancer Society predicts 131,180 lung cancer deaths  in 2022. More-widespread screening could save 30,000–60,000 lives in the United States each year. 

Two big changes happened recently. First, Medicare lowered the recommended age for Screening from 50 to 55, and the American College of Radiology (ACR) has updated it’s Lung Cancer Screening Registry (LCSR) to Version 1.6, and beginning the end of September 2022, will not accept older versions.

Omnicare for Lung, a widely used platform to help manage lung screening and pulmonary nodule patients, has been licensed by the ACR for LungRads and the LCSR, since it’s inception and complies with all Medicare data collection requirements.  Clients using OmniCare Version 8 will meet this new LCSR requirement. 

If you have an older version of OmniCare or are looking for a solution to help you build and grow your Lung Screening Program, contact us at 800-643-0123

Read More

AUGUST 2021: OMNICARE IS CERTIFIED BY THE ACR FOR NMD 3.0

AUGUST 2021: OMNICARE IS CERTIFIED BY THE ACR FOR NMD 3.0

August 2021: Encino, CA: Insight’s OmniCare Breast Center Manager has earned the distinction of being certified by the American College of Radiology (ACR) for their National Mammography Database (NMD) V3.0. Being one of a small handful of company’s to be certified, Insight Clients can now automatically submit their data to the NMD through the OmniCare system.

This Omnicare NMD certification and data submission offers Clients additional quality measures to help fulfill Merit-based Incentive Payment System (MIPS) reporting requirements. Participation also allows for Maintenance of Certification (MOC) Part IV requirements of the American Board of Radiology (ABR).

Read More

Copyright © Insight Management Systems, Inc. All rights reserved.